375 PARK AVENUE,8TH FLOOR
NEW YORK , NY, 10152

Rank

Rank Universe

Summary

The fund seeks capital appreciation by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team focuses on international securities with growth potential that are trading at attractive valuations.More

Link

Directors

Jun 14, 2023
  • Corey Dillon
  • Kevin Mirabile
  • Gerald Hellerman

Chief Compliance Officer

  • Andrew Jones

Fund Manager(s)

Price

  • $ 16.4 ( -0.1 )
    Dec 19, 2024
    Last Close
  • Net Assets
  • $263.8M
    Aug 2, 2023
  • Holding
  • 33
    Aug 2, 2023
    More

  • 52-Week High/Low
  • $18.13 - $15.14
  • Turnover
  • 69%
  • Expense Ratio
  • 0.90%

Company Name

Holding

Novo Nordisk A/S 6.36 %
TSMC 5.92 %
Nestle SA 5.83 %
LVMH Moet Hennessy Louis Vuitt 5.28 %
London Stock Exchange Group PL 4.61 %
Keyence Corp 4.08 %
S&P Global Inc 4.04 %
EssilorLuxottica SA 3.87 %
Diageo PLC 3.84 %
L'Oreal SA 3.78 %
More 3.78 %

Documents

Prospectus

Annual Reports

Fact Sheet

Q2 2019

Performance

YTD

-

3 Year

-0.49%

5 Year

34.98%

Best

29.53%

2019

Worst

-20.39%

2022

Alpha

FCIWX S&P 500

Chart +